Masitinib......hopefully you'll hear more about this
For now,if you go to globenewswire.com and type "Masitinib" into " search" you'll be looking for "AB Science Reports Positive Clinical Study Data" from a phase II trial and now gearing up for phaseIII as a second-line TX for mCRC......
Comments
-
and getting good reports on a phase II trial is somethingcoloCan said:Also,expect to hear more about TAS 102
as well as Cyramza(ramucirumab) in the near future......and maybe pictilisib
called NPC-1C.....while BIBF-1120 is still in play
And for those in need for something new for chemo-induced nausea and vomiting, the FDA recently approved something called Akynzeo......
(Vit D getting major coverage in media today as contributor to CRC survival)
0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.8K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 397 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 671 Leukemia
- 792 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 61 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 539 Sarcoma
- 730 Skin Cancer
- 653 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards